| pubmed-article:9293950 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9293950 | lifeskim:mentions | umls-concept:C0018787 | lld:lifeskim |
| pubmed-article:9293950 | lifeskim:mentions | umls-concept:C0025519 | lld:lifeskim |
| pubmed-article:9293950 | lifeskim:mentions | umls-concept:C0599766 | lld:lifeskim |
| pubmed-article:9293950 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:9293950 | lifeskim:mentions | umls-concept:C1710236 | lld:lifeskim |
| pubmed-article:9293950 | pubmed:issue | 3A | lld:pubmed |
| pubmed-article:9293950 | pubmed:dateCreated | 1997-9-25 | lld:pubmed |
| pubmed-article:9293950 | pubmed:abstractText | The mammalian myocardium meets its high energy needs through the oxidation of a variety of substrates, chiefly fatty acids. This review examines the hypothesis that efficient energy transfer in the heart occurs through a series of moiety-conserved cycles, which makes the heart an obligatory "omnivore." Ischemia results in a transformation of efficient metabolic cycles to less-efficient linear pathways. Substrate metabolism during reperfusion requires the replenishment of depleted cycles and is a major determinant for the return of contractile function. Although there is growing recognition of the concept that regulation of substrate flux through metabolic pathways is shared by several of the pathway enzymes it is apparent that glucose oxidation and glycogen resynthesis promote the return of normal contractile function in the postischemic heart. This concept is supported by clinical observations on the beneficial effects of a solution containing glucose, insulin, and potassium (GIK) for treatment of refractory left ventricular contractile failure after hypothermic ischemic arrest during cardiac surgery. | lld:pubmed |
| pubmed-article:9293950 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9293950 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9293950 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9293950 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9293950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9293950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9293950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9293950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9293950 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9293950 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:9293950 | pubmed:issn | 0002-9149 | lld:pubmed |
| pubmed-article:9293950 | pubmed:author | pubmed-author:TaegtmeyerHH | lld:pubmed |
| pubmed-article:9293950 | pubmed:author | pubmed-author:FrazierO HOH | lld:pubmed |
| pubmed-article:9293950 | pubmed:author | pubmed-author:GoodwinG WGW | lld:pubmed |
| pubmed-article:9293950 | pubmed:author | pubmed-author:DoenstTT | lld:pubmed |
| pubmed-article:9293950 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9293950 | pubmed:day | 4 | lld:pubmed |
| pubmed-article:9293950 | pubmed:volume | 80 | lld:pubmed |
| pubmed-article:9293950 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9293950 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9293950 | pubmed:pagination | 3A-10A | lld:pubmed |
| pubmed-article:9293950 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:9293950 | pubmed:meshHeading | pubmed-meshheading:9293950-... | lld:pubmed |
| pubmed-article:9293950 | pubmed:meshHeading | pubmed-meshheading:9293950-... | lld:pubmed |
| pubmed-article:9293950 | pubmed:meshHeading | pubmed-meshheading:9293950-... | lld:pubmed |
| pubmed-article:9293950 | pubmed:meshHeading | pubmed-meshheading:9293950-... | lld:pubmed |
| pubmed-article:9293950 | pubmed:meshHeading | pubmed-meshheading:9293950-... | lld:pubmed |
| pubmed-article:9293950 | pubmed:meshHeading | pubmed-meshheading:9293950-... | lld:pubmed |
| pubmed-article:9293950 | pubmed:meshHeading | pubmed-meshheading:9293950-... | lld:pubmed |
| pubmed-article:9293950 | pubmed:meshHeading | pubmed-meshheading:9293950-... | lld:pubmed |
| pubmed-article:9293950 | pubmed:meshHeading | pubmed-meshheading:9293950-... | lld:pubmed |
| pubmed-article:9293950 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9293950 | pubmed:articleTitle | Substrate metabolism as a determinant for postischemic functional recovery of the heart. | lld:pubmed |
| pubmed-article:9293950 | pubmed:affiliation | University of Texas-Houston Medical School, Department of Medicine, Texas Heart Institute, 77030, USA. | lld:pubmed |
| pubmed-article:9293950 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9293950 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9293950 | pubmed:publicationType | Review | lld:pubmed |
